LobbyingRecce Pharmaceuticals lobbying by quarter
Recce Pharmaceuticals's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q1 2023; the issues it reports most are Health Issues and Defense.
Recce Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $45K | 1 |
| Q2 2023 | $45K | 1 |
| Q3 2023 | $45K | 1 |
| Q4 2023 | $65K | 2 |
| Q1 2024 | $65K | 2 |
| Q2 2024 | $65K | 2 |
| Q3 2024 | $65K | 2 |
| Q4 2024 | $65K | 2 |
| Q1 2025 | $20K | 2 |
| Q2 2025 | $80K | 2 |
| Q3 2025 | $52K | 2 |
| Q4 2025 | $20K | 2 |
| Q1 2026 | $50K | 2 |
| Q2 2026 | $20K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$195.3K · 15 reports
- Defense$73.3K · 11 reports
- Veterans$73.3K · 11 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- Defense, Dept of (DOD)11 reports
- Health & Human Services, Dept of (HHS)11 reports
- SENATE11 reports
- Defense Threat Reduction Agency (DTRA)10 reports
Firms it paid
| Firm | ||
|---|---|---|
| Horizons Global Solutions | $482K | 14 quarters |
| RK Strategies | $220K | 11 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DAVID FORREST LASSETER | Former Schedule C (DOD), Former Congressional Aide (U.S. House, U.S. Senate) | Q1 2026 |
| JULIE LASSETER | Former Congressional Aide (U.S. House, U.S. Senate), Former Schedule C (DOD) | Q1 2026 |
| STEPHEN ELLIOTT BOYD | Assistant Attorney General at Department of Justice; former Congressional Aide (House and Senate) | Q1 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/18for Q2 | RK Strategies | $20K |
| 07/13for Q2 | Horizons Global Solutions | Under $5,000 |
| 04/20for Q1 | RK Strategies | $20K |
| 04/08for Q1 | Horizons Global Solutions | $30K |
| 02/10for Q4 2025 | Horizons Global Solutions | Under $5,000 |
| 02/10for Q4 2025 | Horizons Global Solutions | Under $5,000 |
| 01/20for Q4 2025 | RK Strategies | $20K |
| 01/08for Q4 2025 | Horizons Global Solutions | Under $5,000 |
| 25/10/20for Q3 2025 | RK Strategies | $20K |
| 25/10/09for Q3 2025 | Horizons Global Solutions | $32K |
| 25/07/21for Q2 2025 | RK Strategies | $20K |
| 25/07/08for Q2 2025 | Horizons Global Solutions | $60K |
| 25/04/21for Q1 2025 | RK Strategies | $20K |
| 25/04/16for Q1 2025 | Horizons Global Solutions | Under $5,000 |
| 25/01/20for Q4 2024 | RK Strategies | $20K |
| 25/01/15for Q4 2024 | Horizons Global Solutions | $45K |
| 24/10/20for Q3 2024 | RK Strategies | $20K |
| 24/10/16for Q3 2024 | Horizons Global Solutions | $45K |
| 24/07/18for Q2 2024 | RK Strategies | $20K |
| 24/07/11for Q2 2024 | Horizons Global Solutions | $45K |